Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters

This article was originally published in The Gold Sheet

Executive Summary

EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.

Advertisement

Related Content

J&J Building Electronic Drug-Tracking System In Anticipation of California’s E-Pedigree
Full Track-and-Trace Anti-Counterfeiting Not Feasible, Industry Tells FDA
California E-Pedigree Law Pushes Final Implementation Back To 2016
Rx Counterfeits: FDA Says Serono Serostim Tracking Is Effective Solution

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS000819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel